PubMed · 1970 · 20 citations · 0 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyDrug MetabolismExperimental PharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismEnzyme InductionHepatic Drug MetabolismHepatic MetabolismHepatotoxicity MechanismsCytochrome P450 Drug MetabolismCytochrome P450 Enzyme ActivityHepatic Microsomal MetabolismMicrosomal Drug MetabolismMicrosomal Enzyme ActivityPhenobarbital TherapyPhenobarbital UseRat Liver Microsomes
3-Amino-1,2,4-triazole was administered to rats in combination with phenobarbital. The hepatic endoplasmic reticulum was studied chemically and by electron microscopy. The increases in cytochrome P-450 and drug hydroxylase activity produced by phenobarbital alone were partially counteracted by administration of aminotriazole together with phenobarbital. The increases in membranes of the endoplasmic reticulum, observed by electron microscopy and measured by microsomal phospholipid, were comparable in animals receiving phenobarbital alone and in combination with aminotriazole. Aminotriazole treatment alone does not produce proliferation of endoplasmic reticular membranes. In the presence of an inducer such as phenobarbital, interference with cytochrome P-450 biosynthesis by aminotriazole does not affect ineduction of the formation of membranes of the hepatic endoplasmic reticulum. These results suggest that induced increases of cytochrome P-450 and of the membranes of endoplasmic reticulum may be controlled by separate mechanisms.